233 related articles for article (PubMed ID: 11802587)
1. Safety considerations for new vaccine development.
Ellenberg SS
Pharmacoepidemiol Drug Saf; 2001; 10(5):411-5. PubMed ID: 11802587
[TBL] [Abstract][Full Text] [Related]
2. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
[TBL] [Abstract][Full Text] [Related]
4. Safety monitoring in vaccine development and immunization.
Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
[TBL] [Abstract][Full Text] [Related]
5. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
6. An analysis of the reactivity of vaccines administered in Texas from 1991 through 1999.
Geier DA; Geier MR
Tex Med; 2002 Jul; 98(7):50-4. PubMed ID: 12134752
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
[TBL] [Abstract][Full Text] [Related]
8. The Vaccine Safety Datalink project.
DeStefano F;
Pharmacoepidemiol Drug Saf; 2001; 10(5):403-6. PubMed ID: 11802585
[TBL] [Abstract][Full Text] [Related]
9. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
[TBL] [Abstract][Full Text] [Related]
10. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
Chang S; Ball R; Braun MM
Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
[TBL] [Abstract][Full Text] [Related]
11. [Adverse events following vaccination reported to the Netherlands Pharmacovigilance Center Lareb in 2004-2006].
Labadie J; van Grootheest AC
Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2738-42. PubMed ID: 18225798
[TBL] [Abstract][Full Text] [Related]
12. Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety.
Haber P; Iskander J; Walton K; Campbell SR; Kohl KS
Pediatrics; 2011 May; 127 Suppl 1():S39-44. PubMed ID: 21502243
[TBL] [Abstract][Full Text] [Related]
13. Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(10):218-22. PubMed ID: 17363890
[TBL] [Abstract][Full Text] [Related]
14. Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS).
Russell M; Pool V; Kelso JM; Tomazic-Jezic VJ
Vaccine; 2004 Dec; 23(5):664-7. PubMed ID: 15542187
[TBL] [Abstract][Full Text] [Related]
15. Vaccine adverse events: separating myth from reality.
Kimmel SR
Am Fam Physician; 2002 Dec; 66(11):2113-20. PubMed ID: 12484693
[TBL] [Abstract][Full Text] [Related]
16. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
17. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project.
Yih WK; Kulldorff M; Fireman BH; Shui IM; Lewis EM; Klein NP; Baggs J; Weintraub ES; Belongia EA; Naleway A; Gee J; Platt R; Lieu TA
Pediatrics; 2011 May; 127 Suppl 1():S54-64. PubMed ID: 21502252
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS).
DiMiceli L; Pool V; Kelso JM; Shadomy SV; Iskander J;
Vaccine; 2006 Feb; 24(6):703-7. PubMed ID: 16154669
[TBL] [Abstract][Full Text] [Related]
19. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.
;
Expert Rev Vaccines; 2009 Jun; 8(6):705-16. PubMed ID: 19485752
[TBL] [Abstract][Full Text] [Related]
20. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception.
Bines JE; Patel M; Parashar U
J Infect Dis; 2009 Nov; 200 Suppl 1():S282-90. PubMed ID: 19817611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
